Genetic testing in renal disease.

Autor: Bockenhauer D; Institute of Child Health, University College London, London, UK. Detlef.Bockenhauer@nhs.net, Medlar AJ, Ashton E, Kleta R, Lench N
Jazyk: angličtina
Zdroj: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2012 Jun; Vol. 27 (6), pp. 873-83. Date of Electronic Publication: 2011 May 27.
DOI: 10.1007/s00467-011-1865-2
Abstrakt: A revolution is happening in genetics! The decoding of the first genome in 2003 was a large international collaborative effort that took about 13 years at a cost of around $2.7 billion. Now, only a few years later, new technology allows the sequencing of an entire genome within a few weeks--and at a cost of less than $10,000. The vaunted $1000 genome is within reach. These extraordinary advances will undoubtedly transform the way we practice medicine. But, like any new technology, it carries risks, as well as benefits. As physicians, we need to understand the implications in order to best utilise these advances for our patients and to provide informed advice. In this review, our aim is to explain these new technologies, to separate the hype from the reality and to address some of the resulting questions and implications. The practical objective is to provide a simple overview of the available technologies and of purpose to which they are best suited.
Databáze: MEDLINE